BSE filing, NSE: JLHL. Summary written from the filing by ALFA Finder's alert engine.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹285.80
- Market cap
- ₹9,369 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 50.3×Sector 53.4×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
Jupiter Life Line Hospitals Acquisition Worth ₹150 Cr
Jupiter Life Line Hospitals executed a sale agreement to acquire 11,452.07 sq m of land in Pune for Rs 150 Crore. The land is where its South Pune hospital project is under development.
- Value
- ₹150.0 Cr
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 436.3 cr (+15.8% YoY), EBITDA Rs 106.9 cr (23.4% margin), PAT Rs 56.4 cr (-1.7%) on Dombivli ramp-up, depreciation and finance costs. Bed capacity expanding from 1,700 to 2,900.
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY
Other share pledge announcements
All →Responsive Industries Share Pledge
Promoter group entity Fairpoint Tradecom LLP released a pledge over 9,99,970 shares worth Rs.14.45 Crore. Promoter holding stays unchanged at 9.25%.
- Value
- ₹14.45 Cr
Responsive Industries Share Pledge
Fairpoint Tradecom LLP, a promoter group entity, released a pledge over 9,99,970 Responsive Industries shares on 3 November 2026. Post-event encumbered holding is 3.04% of share capital.
Ambuja Cements Share Pledge
Ambuja Cements' promoters encumbered 66.94% of share capital as security for facilities up to USD 1.375 billion. The encumbrance covers 99.48% of promoter holding.
- Value
- ₹12,925 Cr
Akme Fintrade (India) Share Pledge
Promoter Manju Devi Jain pledged 1,14,50,000 Akme Fintrade shares (2.55%) to Upsurge Investment & Finance. Post-pledge encumbrance rises to 4.43% of share capital.
Natco Pharma Share Pledge
Natco Pharma promoter V.C. Nannapaneni pledged 8,50,000 equity shares to Bajaj Financial Securities Limited. The pledge supports the promoter's subscription to the company's Rights Issue.
Celebrity Fashions Share Pledge
SBI CAP Trustee, pledge trustee for State Bank of India, disclosed encumbrance of 42,21,966 Celebrity Fashions shares (6.54%). No transaction value is stated in the filing.